AVADEL PHARMACEUTICALS PLC's ticker is and the CUSIP is 05337M904. A total of 3 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $4,114,404 | +104.8% | 243,600 | +71.2% | 0.00% | 0.0% |
Q4 2023 | $2,009,276 | +31.5% | 142,300 | -4.1% | 0.00% | – |
Q3 2023 | $1,528,520 | -13.2% | 148,400 | +39.0% | 0.00% | -100.0% |
Q2 2023 | $1,760,064 | +178.9% | 106,800 | +55.0% | 0.00% | – |
Q1 2023 | $631,124 | -3.9% | 68,900 | -24.9% | 0.00% | – |
Q4 2022 | $656,572 | +910.1% | 91,700 | +244.7% | 0.00% | – |
Q2 2022 | $65,000 | – | 26,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 8,000 | $23,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |